Stivarga
- Licence status
- Active substances
- Regorafenib
- Dosage Form
- Film-coated tablet
- Licence number
- EU/1/13/858/001-002
- Licence holder
- Bayer Pharma AG
Product documents
Licence information
- ATC code
- L01XE Protein kinase inhibitors, L01XE21 regorafenib
- Route of supply
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal products on restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
Stay updated: document advice
The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie